Investigation of the antineoplastic effect of miRNA-181a and development a novel pharmaceutical approaches for treating advanced retinoblastoma

视网膜母细胞瘤（Rb）是儿童眼部最常见的癌症，占所有儿童恶性肿瘤的3%。然而，尽管付出了巨大的努力，在玻璃体腔内生长的持续性或复发性肿瘤仍然是治疗失败的主要原因

Retinoblastoma (Rb) is the most common cancer of the eye in children and accounts for 3% of all childhood malignancies. Yet, despite considerable efforts, persistent or recurrent tumor growing in vitreous cavity is still a major cause of treatment failure